JP2022544581A5 - - Google Patents
Info
- Publication number
- JP2022544581A5 JP2022544581A5 JP2022509577A JP2022509577A JP2022544581A5 JP 2022544581 A5 JP2022544581 A5 JP 2022544581A5 JP 2022509577 A JP2022509577 A JP 2022509577A JP 2022509577 A JP2022509577 A JP 2022509577A JP 2022544581 A5 JP2022544581 A5 JP 2022544581A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- pharmaceutical composition
- composition according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962888055P | 2019-08-16 | 2019-08-16 | |
| US62/888,055 | 2019-08-16 | ||
| PCT/US2020/046439 WO2021034689A1 (en) | 2019-08-16 | 2020-08-14 | Anti-cd83 chimeric antigen receptor expressing t regulatory cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544581A JP2022544581A (ja) | 2022-10-19 |
| JP2022544581A5 true JP2022544581A5 (https=) | 2023-08-18 |
| JP7701908B2 JP7701908B2 (ja) | 2025-07-02 |
Family
ID=74660009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509577A Active JP7701908B2 (ja) | 2019-08-16 | 2020-08-14 | 抗ｃｄ３８キメラ抗原受容体を発現する制御性ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220289862A1 (https=) |
| EP (1) | EP4013447A4 (https=) |
| JP (1) | JP7701908B2 (https=) |
| CN (1) | CN114615992A (https=) |
| AU (1) | AU2020333659A1 (https=) |
| CA (1) | CA3147837A1 (https=) |
| WO (1) | WO2021034689A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019165156A1 (en) | 2018-02-23 | 2019-08-29 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Cd83-binding chimeric antigen receptors |
| AU2020334893A1 (en) * | 2019-08-16 | 2022-02-24 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Chimeric antigen receptors for treating myeloid malignancies |
| WO2023122643A1 (en) * | 2021-12-22 | 2023-06-29 | Regents Of The University Of Minnesota | Cd83 and allo- and autoimmune conditions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040185040A1 (en) * | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
| US9228172B2 (en) * | 2008-06-19 | 2016-01-05 | The Trustees Of The University Of Pennsylvania | Inducible regulatory T-cell generation for hematopoietic transplants |
| JP2013150592A (ja) * | 2011-07-01 | 2013-08-08 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| JP2013040160A (ja) * | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| WO2014117220A1 (en) * | 2013-02-01 | 2014-08-07 | Transbio Ltd | Anti-cd83 antibodies and use thereof |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| KR20180019725A (ko) * | 2015-06-23 | 2018-02-26 | 메모리얼 슬로안-케터링 캔서 센터 | 신규의 피디 1 면역 조절제 |
| KR20180118175A (ko) * | 2016-03-04 | 2018-10-30 | 노파르티스 아게 | 다중 키메라 항원 수용체 (car) 분자를 발현하는 세포 및 그에 따른 용도 |
| EP3684822A4 (en) * | 2017-09-20 | 2021-06-16 | The University of British Columbia | NEW ANTI-HLA-A2 ANTIBODIES AND USES THEREOF |
| WO2019136335A1 (en) * | 2018-01-05 | 2019-07-11 | Gencyte Therapeutics, Inc. | Precision molecular adaptor system for car-t immunotherapy |
| WO2019141774A1 (en) * | 2018-01-19 | 2019-07-25 | Miltenyi Biotec Gmbh | Regulatory t cell expressing a chimeric antigen receptor |
| EP3749334B1 (en) * | 2018-02-08 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | Allogenic hematopoietic stem cell transplantation |
| WO2019165156A1 (en) * | 2018-02-23 | 2019-08-29 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Cd83-binding chimeric antigen receptors |
-
2020
- 2020-08-14 AU AU2020333659A patent/AU2020333659A1/en active Pending
- 2020-08-14 JP JP2022509577A patent/JP7701908B2/ja active Active
- 2020-08-14 EP EP20854296.9A patent/EP4013447A4/en active Pending
- 2020-08-14 CA CA3147837A patent/CA3147837A1/en active Pending
- 2020-08-14 CN CN202080063859.0A patent/CN114615992A/zh active Pending
- 2020-08-14 US US17/635,119 patent/US20220289862A1/en active Pending
- 2020-08-14 WO PCT/US2020/046439 patent/WO2021034689A1/en not_active Ceased